Short Report

Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?

Foley JE, Bhosekar V, Kawamori R

Vascular Health and Risk Management 2016, 12:9-12

Published Date: 21 January 2016